AVB-001
- Generic Name
- AVB-001
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
AVB-001 is an encapsulated, engineered human ARPE-19 cell line that constitutively expresses the native human IL-2 cytokine
- Associated Conditions
- -
- Associated Therapies
- -
Frontotemporal dementia: The state of treatment development
Bruce Willis's FTD diagnosis has spotlighted research into this incurable condition. Studies focus on gene therapies, ASOs, and the genetic overlap with ALS. Early detection and treatment are crucial, with efforts underway to identify biomarkers and develop targeted therapies for FTD's varied genetic causes.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath